# NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression

> **NCT02294591** · PHASE2 · COMPLETED · sponsor: **Region Syddanmark** · enrollment: 80 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02294591
- **Lead sponsor:** Region Syddanmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294591, "NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02294591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*